#1 Clinical Trials Search in Europe

CHLORMADINONE ACETATE

Chlormadinone acetate is a synthetic progestagen (a type of hormone) that has been studied in clinical trials for different medical purposes. These trials have investigated its use in postmenopausal hormone therapy and as a component in oral contraceptive pills. This article explores how chlormadinone acetate has been evaluated in clinical research, focusing on its effects on gene expression in postmenopausal women and its impact on body weight and other side effects when used for contraception. Understanding these clinical trials helps provide insights into how this medication works and its potential benefits and side effects compared to other similar treatments.

Table of Contents

What is Chlormadinone Acetate?

Chlormadinone acetate is a synthetic progestin (a laboratory-made version of the natural female hormone progesterone). It belongs to a specific category called C-21 progestins. The medication is often sold under brand names such as Belara® (when combined with ethinylestradiol) and Luteran®[1].

Medical Uses

Based on clinical trial data, chlormadinone acetate is used for several medical purposes:

  • Contraception (birth control): When combined with ethinylestradiol (a synthetic estrogen) in oral contraceptive pills like Belara®, it prevents pregnancy[2].
  • Hormone Therapy: Used in postmenopausal women as part of hormone replacement therapy, typically combined with 17β-estradiol[1].

How It Works

Chlormadinone acetate works in multiple ways in the body:

  • It has progestogenic effects (similar to natural progesterone)[1].
  • It possesses antiandrogenic properties, which means it blocks the effects of male hormones in the body[2].
  • It also has some glucocorticoid effects, which relates to metabolism and immune response[2].

Administration and Dosage

According to the clinical trials reviewed:

  • For contraception: Typically administered as 2 mg chlormadinone acetate combined with 30 mcg ethinylestradiol (Belara®), taken as one tablet daily for 21 days followed by a 7-day break[2].
  • For postmenopausal hormone therapy: Used at a dosage of 5 mg/day orally, often combined with 0.05 mg/day transdermal (through the skin) 17β-estradiol[1].

Comparison with Other Progestins

Clinical trials have compared chlormadinone acetate with other progestins:

  • Natural progesterone: One study compared chlormadinone acetate to natural progesterone in postmenopausal hormone therapy, looking at effects on gene expression in blood cells[1].
  • Drospirenone: Another study compared chlormadinone acetate (in Belara®) with drospirenone (in Yasmin®) for contraceptive use, focusing particularly on body weight changes and other side effects[2].

While chlormadinone acetate has glucocorticoid and antiandrogenic effects, drospirenone (another progestin) has antimineralocorticoid (affects fluid balance) and antiandrogenic effects[2].

Side Effects and Considerations

Clinical trials have investigated several potential side effects of chlormadinone acetate:

  • Body weight changes: This was a primary focus of comparison between chlormadinone acetate and drospirenone in contraceptive use[2].
  • Vaginal spotting: Breakthrough bleeding between periods was monitored in studies[2].
  • Androgenic effects: Because of its antiandrogenic properties, chlormadinone acetate might cause fewer androgenic side effects (like acne or excess hair growth) compared to some other progestins[2].
  • Blood pressure effects: These were monitored in clinical trials[2].
  • Headaches and gastrointestinal effects: These were also tracked as potential side effects[2].

Potential Benefits

Based on its properties, chlormadinone acetate may offer certain advantages:

  • Antiandrogenic effects: May be beneficial for women with conditions related to excess androgen activity, such as acne or hirsutism (excess hair growth)[2].
  • Potential for minimal weight gain: Research has specifically looked at body weight changes with this medication, suggesting this might be a consideration in its use[2].

Current Research Studies

Chlormadinone acetate has been involved in several clinical trials:

  1. Postmenopausal Hormone Therapy Study: Comparing natural progesterone to chlormadinone acetate in combination with estradiol, examining effects on gene expression in blood cells, quality of life, and various blood markers over 12 months[1].
  2. Contraceptive Comparison Study: Comparing contraceptive pills containing chlormadinone acetate (Belara®) with those containing drospirenone (Yasmin®), specifically looking at body weight changes, contraceptive effectiveness, side effects, and user satisfaction over 6 months[2].

These studies aim to better understand how different progestins work in the body and help healthcare providers select the most appropriate medication for each individual patient’s needs.

Aspect Chlormadinone Acetate in Hormone Therapy Chlormadinone Acetate in Contraception (Belara®)
Dosage 5 mg/day oral + 0.05 mg/day transdermal 17β-estradiol 2 mg chlormadinone acetate + 30 mcg ethinylestradiol
Comparison Group Natural progesterone (200 mg/day) Drospirenone (3 mg) + 30 mcg ethinylestradiol (Yasmin®)
Primary Outcome Measured Blood gene expression profiling (transcriptome) Body weight change
Secondary Outcomes Quality of life, proteome, haemostatic variables Contraceptive efficacy, side effects (spotting, androgenic effects, blood pressure, headache, GI effects), user satisfaction
Duration of Study 12 months 6 months (6 cycles)
Administration Daily oral pill with transdermal estradiol patch 1 tablet daily for 21 days, followed by 7-day break
Pharmacological Properties Synthetic progestagen C-21 progestin with glucocorticoid and antiandrogenic effects

FAQ

  • What is chlormadinone acetate and what is it used for? Chlormadinone acetate is a synthetic progestagen (a type of hormone that acts similar to progesterone). Based on the clinical trials data, it's used in two main ways: 1) as part of combined hormone therapy for postmenopausal women, typically combined with estradiol, and 2) as a component in oral contraceptive pills (OCPs), where it's combined with ethinylestradiol (as in the brand Belara®).
  • How does chlormadinone acetate compare to natural progesterone in hormone therapy? One of the clinical trials specifically compared chlormadinone acetate to natural progesterone in postmenopausal hormone therapy. The study examined how these different progestagens affect gene expression in blood, as well as quality of life, protein profiles, and blood clotting factors. Both treatments were combined with the same form of estrogen (transdermal 17β-estradiol). The trial aimed to determine if there are significant differences at the molecular level between synthetic and natural hormone options.
  • Does chlormadinone acetate cause weight gain when used in contraceptive pills? Body weight change was the primary focus of one clinical trial that compared two different contraceptive pills: one containing chlormadinone acetate (Belara®) and another containing drospirenone (Yasmin®). Both pills contained the same amount of ethinylestradiol (30 mcg). The study specifically examined weight changes over 6 months of use. This research was designed to help determine which progestin might have less impact on body weight, as weight gain is a common concern and reason why some women stop using contraceptive pills.
  • What side effects were studied with chlormadinone acetate contraceptives? In the contraceptive trial comparing chlormadinone acetate (Belara®) to drospirenone (Yasmin®), researchers examined several side effects beyond just weight change. These included vaginal spotting (breakthrough bleeding), androgenic effects (like acne and excess hair growth), blood pressure changes, headaches, and gastrointestinal discomfort. The study also measured user satisfaction with the contraceptives across various factors including overall satisfaction and pill quality.
  • What are the potential benefits of chlormadinone acetate compared to other progestins? According to the trial information, chlormadinone acetate is a C-21 progestin that has glucocorticoid and antiandrogenic effects. This means it may help reduce symptoms related to excess male hormones, such as acne or unwanted hair growth. The research suggests that chlormadinone might have fewer effects on body weight compared to some other progestins, although the trials were specifically designed to measure these differences compared to drospirenone (which also has antiandrogenic properties). Both progestins studied were selected because they might offer certain non-contraceptive benefits beyond preventing pregnancy.

Ongoing Clinical Trials on CHLORMADINONE ACETATE

  • Study on the Effects of Ethinylestradiol, Levonorgestrel, and Chlormadinone Acetate in Hormonal Contraception for Women Using Oral Contraceptives

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria

Glossary

  • Progestagen/Progestin: Hormones that produce effects similar to progesterone. They can be natural (like progesterone itself) or synthetic (like chlormadinone acetate). They're used in hormone therapy and contraceptives.
  • Chlormadinone Acetate: A synthetic progestin (C-21 type) with glucocorticoid and antiandrogenic effects. Used in postmenopausal hormone therapy and contraceptive pills.
  • Postmenopausal Hormone Therapy (HT): Treatment that provides hormones that the body stops making after menopause, often combining estrogen with a progestagen to relieve symptoms and prevent certain health effects of menopause.
  • Transcriptome: The complete set of RNA molecules (gene transcripts) produced by the genome in a specific cell or tissue. Studying the transcriptome helps understand which genes are active.
  • Gene Expression Profiling: A laboratory technique that measures the activity (expression) of thousands of genes at once, creating a global picture of cellular function.
  • Pharmacogenomics: The study of how genes affect a person's response to drugs, combining pharmacology (the science of drugs) and genomics (the study of genes and their functions).
  • Oral Combined Contraceptive Pills (OCP): Birth control pills that contain synthetic versions of both estrogen and progesterone hormones to prevent pregnancy.
  • Ethinylestradiol: A synthetic form of estrogen commonly used in birth control pills, including those containing chlormadinone acetate (like Belara®).
  • Drospirenone: A synthetic progestin derived from spironolactone with antimineralocorticoid and antiandrogenic properties, used in some contraceptive pills (like Yasmin®).
  • Transdermal: A route of administration where medication is delivered through the skin, often via a patch (as with the estradiol in the hormone therapy trial).
  • Antiandrogenic Effect: The ability of a substance to block or reduce the effects of male hormones (androgens), which can help with conditions like acne, excess hair growth, and female pattern hair loss.
  • Antimineralocorticoid Effect: The ability to oppose the action of aldosterone (a hormone that increases sodium retention and potassium excretion), potentially helping prevent water retention and related weight gain.
  • Glucocorticoid Effect: Actions similar to cortisol (a stress hormone), which can affect metabolism, immune response, and other bodily functions.
  • Vaginal Spotting: Light bleeding from the vagina between menstrual periods, which can be a side effect of hormonal contraceptives.
  • Systems Biology: A field that studies complex interactions within biological systems, looking at the system as a whole rather than just its individual parts.
  • Proteome: The entire set of proteins expressed by a cell, tissue, or organism. Studying the proteome can reveal how cells function under different conditions.
  • Haemostatic Variables: Factors in the blood that affect clotting, which can be influenced by hormone therapy.
  • Micronized: A process that reduces the particle size of a substance to improve its absorption by the body, as with the natural progesterone used in the hormone therapy trial.

References

  1. https://clinicaltrials.gov/study/NCT01123538
  2. https://clinicaltrials.gov/study/NCT01608698